HELLS
Lymphoid-specific helicase
Also known as: HELLS_HUMAN, LSH, Nbla10143, PASG, SMARCA6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRZ9
- Gene
- HELLS
- Ensembl
- ENSG00000119969
- Chromosome
- 10
- Canonical length
- 838 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Vesicles
OverviewNCBI Gene
This gene encodes a lymphoid-specific helicase. Other helicases function in processes involving DNA strand separation, including replication, repair, recombination, and transcription. This protein is thought to be involved with cellular proliferation and may play a role in leukemogenesis. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
838 residues, UniProt reviewed canonical sequence.
>Q9NRZ9|HELLS
1 MPAERPAGSG GSEAPAMVEQ LDTAVITPAM LEEEEQLEAA GLERERKMLE KARMSWDRES
61 TEIRYRRLQH LLEKSNIYSK FLLTKMEQQQ LEEQKKKEKL ERKKESLKVK KGKNSIDASE
121 EKPVMRKKRG REDESYNISE VMSKEEILSV AKKNKKENED ENSSSTNLCV EDLQKNKDSN
181 SIIKDRLSET VRQNTKFFFD PVRKCNGQPV PFQQPKHFTG GVMRWYQVEG MEWLRMLWEN
241 GINGILADEM GLGKTVQCIA TIALMIQRGV PGPFLVCGPL STLPNWMAEF KRFTPDIPTM
301 LYHGTQEERQ KLVRNIYKRK GTLQIHPVVI TSFEIAMRDR NALQHCYWKY LIVDEGHRIK
361 NMKCRLIREL KRFNADNKLL LTGTPLQNNL SELWSLLNFL LPDVFDDLKS FESWFDITSL
421 SETAEDIIAK EREQNVLHML HQILTPFLLR RLKSDVALEV PPKREVVVYA PLSKKQEIFY
481 TAIVNRTIAN MFGSSEKETI ELSPTGRPKR RTRKSINYSK IDDFPNELEK LISQIQPEVD
541 RERAVVEVNI PVESEVNLKL QNIMMLLRKC CNHPYLIEYP IDPVTQEFKI DEELVTNSGK
601 FLILDRMLPE LKKRGHKVLL FSQMTSMLDI LMDYCHLRDF NFSRLDGSMS YSEREKNMHS
661 FNTDPEVFIF LVSTRAGGLG INLTAADTVI IYDSDWNPQS DLQAQDRCHR IGQTKPVVVY
721 RLVTANTIDQ KIVERAAAKR KLEKLIIHKN HFKGGQSGLN LSKNFLDPKE LMELLKSRDY
781 EREIKGSREK VISDKDLELL LDRSDLIDQM NASGPIKEKM GIFKILENSE DSSPECLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HELLS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- thymus: 11 nTPM
- bone marrow: 9.2 nTPM
- tonsil: 9 nTPM
- testis: 8.7 nTPM
- lymph node: 8 nTPM
- cerebellum: 5.5 nTPM
Single-cell type
- early primary spermatocytes: 224 nCPM
- differentiating spermatogonia: 155 nCPM
- respiratory deuterosomal cells: 149 nCPM
- erythrocyte progenitors: 138 nCPM
- megakaryocyte progenitors: 117 nCPM
- monocyte progenitors: 107 nCPM
Immune cell
- T-reg: 3.1 nTPM
- NK-cell: 2.8 nTPM
- memory CD8 T-cell: 1.9 nTPM
- plasmacytoid DC: 1.6 nTPM
- memory B-cell: 1.1 nTPM
- memory CD4 T-cell: 1.1 nTPM
Brain region
- cerebellum: 7.5 nTPM
- white matter: 3.5 nTPM
- cerebral cortex: 3.3 nTPM
- hypothalamus: 3.3 nTPM
- medulla oblongata: 3.1 nTPM
- midbrain: 3.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HELLS.
Disease | AllUniProt
Conditions HELLS is implicated in, by any mechanism.
- Immunodeficiency-centromeric instability-facial anomalies syndrome 4 (ICF4) MIM:616911
Disease | GeneticClinVar
20 pathogenic / likely-pathogenic of 479 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency-centromeric instability-facial anomalies syndrome 4
- HELLS-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.99
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell division
- cellular response to leukemia inhibitory factor
- chromosomal DNA methylation maintenance following DNA replication
- DNA methylation-dependent constitutive heterochromatin formation
- double-strand break repair
- double-strand break repair via homologous recombination
- kidney development
- lymphocyte proliferation
- negative regulation of gene expression via chromosomal CpG island methylation
- negative regulation of intrinsic apoptotic signaling pathway
- pericentric heterochromatin formation
- urogenital system development
Molecular functions
- ATP binding
- ATP-dependent chromatin remodeler activity
- chromatin binding
- chromatin-protein adaptor activity
- helicase activity
- hydrolase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SNF2, N-terminal domain
- Helicase, C-terminal domain-like
- Helicase superfamily 1/2, ATP-binding domain
- P-loop containing nucleoside triphosphate hydrolase
- SNF2-like, N-terminal domain superfamily
- SNF2/RAD5-like, C-terminal helicase domain
- SNF2-related domain
- Helicase conserved C-terminal domain
- HELLS, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HELLS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HELLS as an antibody target. Whether an autoantibody or antibody against HELLS could matter depends on whether native HELLS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HELLS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HELLS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...